RopesTalk

In this Ropes & Gray podcast, asset management partners Adam Dobson, Isabel Dische and Lindsey Goldstein discuss fund recapitalization transactions and a recent trend by some sponsors toward pursuing these transactions without a lead secondary buyer, and certain key risks for both fund sponsors and secondary buyers.

On March 10, 2021, former Chief Judge of the D.C. Circuit Merrick Garland was confirmed by the Senate as the new United States Attorney General. In this Ropes & Gray Capital Insights podcast, litigation & enforcement partners Brian Blais and Lisa Bebchick examine the DOJ enforcement priorities for 2021 and beyond.

In this Ropes & Gray podcast, U.S.-based capital solutions partner Alyson Gal is joined by her London-based business restructuring colleagues, partner Matt Czyzyk and associate Natalie Raine, to discuss recent developments in European restructuring regimes and the implications of these changes on the tools available to investors in European distressed situations. The discussion includes how restructurings have historically been handled in Europe; the impact of the 2020 Corporate Insolvency and Governance Act (CIGA), including the introduction of a new pre-insolvency tool known as the Part 26A restructuring plan; the various applications of the 2019 European Union directive on preventative restructuring frameworks by the Member States; as well as temporary measures put into place in Europe to support companies impacted by the global pandemic.

The week of March 1st, the Center for Medicare and Medicaid Innovation (CMMI) officially delayed and suspended three of its programs, two of which, the Kidney Care Choices model and Seriously Ill Populations (SIP) track of the Primary Care First model, were set to begin on April 1. The Geographic Direct Contracting model has been indefinitely suspended, and CMMI made changes to the terms of the Direct Contracting model. In this Ropes & Gray podcast, health care partner, Christina Bergeron, and health care counsel, Sarah Blumenthal, discuss these actions, their implications and recommended next steps for providers, groups, and others participating, or interested in participating, in these programs.

In this second episode of our Ropes & Gray podcast series addressing emerging issues for fiduciaries of 401(k) and 403(b) plans to consider as part of their litigation risk management strategy, ERISA & benefits partner Josh Lichtenstein and benefits principal David Kirchner discuss the importance of implementing a robust cybersecurity program for benefit plans to ensure that participant and beneficiary information and plan assets are properly protected.

Ropes & Gray’s podcast series Conductive Discussions focuses on legal issues of interest to the semiconductor industry. In this episode, IP litigation partners Mark Rowland and Andrew Radsch, and associates Daniel Richards and James Mack, discuss patent infringement under section 271(g) of the Patent Act, a frequently overlooked but powerful provision. The team explores the statutory exceptions to liability, the availability of burden-shifting when proving infringement, and unique damages limitations for claims under section 271(g).

In this edition of Ropes & Gray’s podcast series On the Ropes: Enforcement Risk Roundtable, litigation partner Colleen Conry and associate Kyle Zipf provide an update on the anti-corruption landscape and related developments in Ghana following the country’s recent presidential and parliamentary elections.

This installation of Ropes & Gray’s podcast series Non-binding Guidance focuses on FDA regulatory developments in the area of artificial intelligence (“AI”) and machine learning. AI and machine learning represent a rapidly growing frontier in digital health, with applications ranging from medical device software used for diagnostic and triaging applications to drug candidate selection to clinical trial design and interpretation. In this episode, FDA regulatory attorneys Kellie Combs, Greg Levine, and Sarah Blankstein explore the development and uptake of these technologies in response to the ongoing COVID-19 pandemic, FDA’s current regulatory landscape for these technologies, recent steps FDA has taken to update its regulatory approach to these tools in coordination with industry, and continuing trends in this area they expect to see through 2021.

In this next installment of our ETF podcast series, Ropes & Gray attorneys Brian McCabe, Jeremy Smith and Ed Baer discuss some of the issues facing non-ETF managers who are contemplating getting into the ETF space.

In this Ropes & Gray podcast, partner Ama Adams, counsel Brendan Hanifin, and associate Emerson Siegle discuss the implications and key questions surrounding Executive Order 13959, “Addressing the Threat from Securities Investments that Finance Communist China Military Companies.”